Preclinical In-vivo Imaging System Market by Modality and Reagent - Global Industry Analysis & Forecast to 2027
Published On : January 2020 Pages : 158 Category: Pharma & Healthcare Report Code : HC018447
Preclinical In-vivo Imaging System Market by Modality (Nuclear Imaging, Optical Imaging, Micro-CT, Micro-Ultrasound, Photoacoustic, Micro-MRI, Other) Reagent (Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents, Other) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The preclinical in-vivo imaging system market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. In vivo imaging of small animals is progressively being conveyed over the medication advancement process, especially in the oncology or cancer therapeutic area. One of the primary applications is observing the treatment reaction for early signs of viability. The most utilized imaging modalities are at present optical (bioluminescence and fluorescence), magnetic resonance imaging (MRI) and positron discharge tomography (PET). Single methodology imaging prevails, with multi-methodology at present got to for the most part through coregistration with other imaging modes. In vivo imaging is relied upon to have most prominent effect in drug development through checking sickness movement and restorative reaction in longitudinal examinations. In vivo preclinical imaging is ready to quickly progress, to such an extent that the specification and abilities of small animal imagers will soon long surpass their clinical counterparts.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global preclinical in-vivo imaging system market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Aspect Imaging
- FUJIFILM VisualSonics, Inc.
- MR Solutions Ltd
- Biospace Lab S.A.
- TriFoil Imaging
- Mediso Ltd.
- Bruker Corporation
- PerkinElmer, Inc.
- MILabs B.V.
- LI-COR Biosciences
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Preclinical In-vivo Imaging System Market, By Modality, Estimates and Forecast, 2017-2027 ($Million)
o Nuclear Imaging
o Optical Imaging
o Micro-CT
o Micro-Ultrasound
o Photoacoustic
o Micro-MRI
o Other
· Preclinical In-vivo Imaging System Market, By Reagent, Estimates and Forecast, 2017-2027 ($Million)
o Nuclear Imaging Reagents
o MRI Contrast Agents
o Ultrasound Contrast Agents
o CT Contrast Agents
o Other
· Preclinical In-vivo Imaging System Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Aspect Imaging
o FUJIFILM VisualSonics, Inc.
o MR Solutions Ltd
o Biospace Lab S.A.
o TriFoil Imaging
o Mediso Ltd.
o Bruker Corporation
o PerkinElmer, Inc.
o MILabs B.V.
o LI-COR Biosciences
· Preclinical In-vivo Imaging System Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Preclinical In-vivo Imaging System Market, By Country
o U.S. Preclinical In-vivo Imaging System Market
o Canada Preclinical In-vivo Imaging System Market
o Mexico Preclinical In-vivo Imaging System Market
o Europe
§ Europe Preclinical In-vivo Imaging System Market, By Country
o Germany Preclinical In-vivo Imaging System Market
o UK Preclinical In-vivo Imaging System Market
o France Preclinical In-vivo Imaging System Market
o Russia Preclinical In-vivo Imaging System Market
o Italy Preclinical In-vivo Imaging System Market
o Rest of Europe Preclinical In-vivo Imaging System Market
o Asia-Pacific
§ Asia-Pacific Preclinical In-vivo Imaging System Market, By Country
o China Preclinical In-vivo Imaging System Market
o Japan Preclinical In-vivo Imaging System Market
o South Korea Preclinical In-vivo Imaging System Market
o India Preclinical In-vivo Imaging System Market
o Southeast Asia Preclinical In-vivo Imaging System Market
o Rest of Asia-Pacific Preclinical In-vivo Imaging System Market
o South America
§ South America Preclinical In-vivo Imaging System Market
o Brazil Preclinical In-vivo Imaging System Market
o Argentina Preclinical In-vivo Imaging System Market
o Columbia Preclinical In-vivo Imaging System Market
o Rest of South America Preclinical In-vivo Imaging System Market
o Middle East and Africa
§ Middle East and Africa Preclinical In-vivo Imaging System Market
o Saudi Arabia Preclinical In-vivo Imaging System Market
o UAE Preclinical In-vivo Imaging System Market
o Egypt Preclinical In-vivo Imaging System Market
o Nigeria Preclinical In-vivo Imaging System Market
o South Africa Preclinical In-vivo Imaging System Market
o Rest of MEA Preclinical In-vivo Imaging System Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Preclinical In-vivo Imaging System Market, By Modality
5.1. Introduction
5.2. Global Preclinical In-vivo Imaging System Revenue and Market Share by Modality (2017-2027)
5.2.1. Global Preclinical In-vivo Imaging System Revenue and Revenue Share by Modality (2017-2027)
5.3. Nuclear Imaging
5.3.1. Global Nuclear Imaging Revenue and Growth Rate (2017-2027)
5.4. Optical Imaging
5.4.1. Global Optical Imaging Revenue and Growth Rate (2017-2027)
5.5. Micro-CT
5.5.1. Global Micro-CT Revenue and Growth Rate (2017-2027)
5.6. Micro-Ultrasound
5.6.1. Global Micro-Ultrasound Revenue and Growth Rate (2017-2027)
5.7. Photoacoustic
5.7.1. Global Photoacoustic Revenue and Growth Rate (2017-2027)
5.8. Micro-MRI
5.8.1. Global Micro-MRI Revenue and Growth Rate (2017-2027)
5.9. Other
5.9.1. Global Other Revenue and Growth Rate (2017-2027)
6. Preclinical In-vivo Imaging System Market, By Application
6.1. Introduction
6.2. Global Preclinical In-vivo Imaging System Revenue and Market Share by Application (2017-2027)
6.2.1. Global Preclinical In-vivo Imaging System Revenue and Revenue Share by Application (2017-2027)
6.3. Nuclear Imaging Reagents
6.3.1. Global Nuclear Imaging Reagents Revenue and Growth Rate (2017-2027)
6.4. MRI Contrast Agents
6.4.1. Global MRI Contrast Agents Revenue and Growth Rate (2017-2027)
6.5. Ultrasound Contrast Agents
6.5.1. Global Ultrasound Contrast Agents Revenue and Growth Rate (2017-2027)
6.6. CT Contrast Agents
6.6.1. Global CT Contrast Agents Revenue and Growth Rate (2017-2027)
6.7. Other
6.7.1. Global Other Revenue and Growth Rate (2017-2027)
7. Preclinical In-vivo Imaging System Market, By Region
7.1. Introduction
7.2. Global Preclinical In-vivo Imaging System Revenue and Market Share by Regions
7.2.1. Global Preclinical In-vivo Imaging System Revenue by Regions (2017-2027)
7.3. North America Preclinical In-vivo Imaging System by Countries
7.3.1. North America Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2027)
7.3.2. North America Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Preclinical In-vivo Imaging System by Countries
7.4.1. Europe Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2027)
7.4.2. Europe Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Preclinical In-vivo Imaging System by Countries
7.5.1. Asia-Pacific Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Preclinical In-vivo Imaging System by Countries
7.6.1. South America Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2027)
7.6.2. South America Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Preclinical In-vivo Imaging System by Countries
7.7.1. Middle East and Africa Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Aspect Imaging
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. FUJIFILM VisualSonics, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. MR Solutions Ltd
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Biospace Lab S.A.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. TriFoil Imaging
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Mediso Ltd.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Bruker Corporation
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. PerkinElmer, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. MILabs B.V.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. LI-COR Biosciences
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.1. Global Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Preclinical In-vivo Imaging System Market Forecast by Regions (2017-2027)
9.2.1. North America Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.1.1. United States Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.1.2. Canada Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.1.3. Mexico Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2. Europe Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2.1. Germany Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2.2. France Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2.3. UK Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2.4. Russia Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2.5. Italy Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3. Asia-Pacific Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3.1. China Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3.2. Japan Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3.3. Korea Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3.4. India Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.4. South America Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.4.1. Brazil Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.4.2. Argentina Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.4.3. Columbia Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.4.4. Rest of South America Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5. Middle East and Africa Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.3. Egypt Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.4. Nigeria Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.5. South Africa Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.6. Turkey Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Preclinical In-vivo Imaging System Market Forecast (2017-2027)
9.3. Preclinical In-vivo Imaging System Market Forecast by Modality (2017-2027)
9.3.1. Preclinical In-vivo Imaging System Forecast by Modality (2017-2027)
9.3.2. Preclinical In-vivo Imaging System Market Share Forecast by Modality (2017-2027)
9.4. Preclinical In-vivo Imaging System Market Forecast by Application (2017-2027)
9.4.1. Preclinical In-vivo Imaging System Forecast by Application (2017-2027)
9.4.2. Preclinical In-vivo Imaging System Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Preclinical In-vivo Imaging System Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Preclinical In-vivo Imaging System Revenue and Revenue Share by Modality (2017-2018)
Figure Global Nuclear Imaging Revenue and Growth Rate (2017-2018)
Figure Global Optical Imaging Revenue and Growth Rate (2017-2018)
Figure Global Micro-CT Revenue and Growth Rate (2017-2018)
Figure Global Micro-Ultrasound Revenue and Growth Rate (2017-2018)
Figure Global Photoacoustic Revenue and Growth Rate (2017-2018)
Figure Global Micro-MRI Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Preclinical In-vivo Imaging System Revenue and Revenue Share by Application (2017-2018)
Figure Global Nuclear Imaging Reagents Revenue and Growth Rate (2017-2018)
Figure Global MRI Contrast Agents Revenue and Growth Rate (2017-2018)
Figure Global Ultrasound Contrast Agents Revenue and Growth Rate (2017-2018)
Figure Global CT Contrast Agents Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Preclinical In-vivo Imaging System Revenue by Regions (2017-2018)
Figure North America Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure North America Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2018)
Figure North America Preclinical In-vivo Imaging System by Countries (2017-2018)
Figure North America Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2018)
Figure United States Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure United States Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Canada Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Mexico Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Europe Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2018)
Figure Europe Preclinical In-vivo Imaging System by Countries (2017-2018)
Figure Europe Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2018)
Figure Germany Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Germany Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure France Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure UK Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Russia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Italy Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Rest of Europe Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Asia-Pacific Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Preclinical In-vivo Imaging System by Countries (2017-2018)
Figure Asia-Pacific Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2018)
Figure China Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure China Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Japan Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Korea Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure India Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Southeast Asia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure South America Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2018)
Figure South America Preclinical In-vivo Imaging System by Countries (2017-2018)
Figure South America Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Brazil Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Argentina Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Columbia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Rest of South America Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Middle East and Africa Preclinical In-vivo Imaging System Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Preclinical In-vivo Imaging System by Countries (2017-2018)
Figure Middle East and Africa Preclinical In-vivo Imaging System Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Saudi Arabia Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure United Arab Emirates Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Egypt Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Nigeria Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure South Africa Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Turkey Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preclinical In-vivo Imaging System Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2017-2018)
Table Aspect Imaging Preclinical In-vivo Imaging System Financial Overview
Table FUJIFILM VisualSonics, Inc. Preclinical In-vivo Imaging System Financial Overview
Table MR Solutions Ltd Preclinical In-vivo Imaging System Financial Overview
Table Biospace Lab S.A. Preclinical In-vivo Imaging System Financial Overview
Table TriFoil Imaging Preclinical In-vivo Imaging System Financial Overview
Table Mediso Ltd. Preclinical In-vivo Imaging System Financial Overview
Table Bruker Corporation Preclinical In-vivo Imaging System Financial Overview
Table PerkinElmer, Inc. Preclinical In-vivo Imaging System Financial Overview
Table MILabs B.V. Preclinical In-vivo Imaging System Financial Overview
Table LI-COR Biosciences Preclinical In-vivo Imaging System Financial Overview
Figure Global Preclinical In-vivo Imaging System Revenue (Millions USD) and Growth Rate (2018-2025)
Table Preclinical In-vivo Imaging System Market Forecast by Regions (2018-2025)
Figure North America Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure United States Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Canada Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Mexico Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Europe Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Germany Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure France Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure UK Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Russia Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Italy Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Rest of Europe Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Asia-Pacific Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure China Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Japan Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Korea Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure India Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Southeast Asia Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure South America Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Brazil Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Argentina Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Columbia Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Rest of South America Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Middle East and Africa Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Saudi Arabia Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure United Arab Emirates Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Egypt Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Nigeria Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure South Africa Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Turkey Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Preclinical In-vivo Imaging System Market Forecast (2018-2025)
Figure Global Preclinical In-vivo Imaging System Forecast by Modality (2018-2025)
Figure Global Preclinical In-vivo Imaging System Market Share Forecast by Modality (2018-2025)
Figure Global Preclinical In-vivo Imaging System Forecast by Modality (2018-2025)
Figure Global Preclinical In-vivo Imaging System Forecast by Application (2018-2025)
Figure Global Preclinical In-vivo Imaging System Market Share Forecast by Application (2018-2025)
Figure Global Preclinical In-vivo Imaging System Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|